⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9651313 | 1.00 | — | — | |
| Trifluoroacetic Acid SCHEMBL22411272 | 0.87 | GRIK1 (0.36) | — | |
| SCHEMBL6038444 | 0.81 | — | — | |
| SCHEMBL7322804 | 0.81 | — | — | |
| SCHEMBL10763431 | 0.80 | — | — | |
| SCHEMBL29915633 | 0.80 | — | — | |
| SCHEMBL28666593 | 0.79 | — | — | |
| SCHEMBL27860724 | 0.77 | GRIK1 (0.31) | — | |
| SCHEMBL8767655 | 0.75 | GRIK1 (0.34) | — | |
| SCHEMBL8767650 | 0.75 | GRIK1 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4736944-A2 | POLYPEPTIDES AND USES THEREOF | MedImmune Limited (GB) | 2026-05-06 | — | — | EP | claimed |
| US-20240067693-A1 | POLYPEPTIDES AND USES THEREOF | MEDIMMUNE LIMITED (GB) | 2024-02-29 | — | — | US | claimed |
| EP-4263586-A1 | POLYPEPTIDES AND USES THEREOF | MedImmune Limited (GB) | 2023-10-25 | — | — | EP | claimed |
| US-20220242910-A1 | AGONIST OF SPEXIN-BASED GALANIN TYPE 2 RECEPTOR AND USE THEREOF | NEURACLE SCIENCE CO., LTD. (KR) | 2022-08-04 | — | — | US | claimed |
| US-20220204580-A1 | POLYPEPTIDES AND USES THEREOF | MEDIMMUNE LIMITED (GB) | 2022-06-30 | — | — | US | claimed |
| WO-2022129254-A1 | POLYPEPTIDES AND USES THEREOF | MEDIMMUNE LIMITED (GB) | 2022-06-23 | — | — | WO | claimed |
| EP-1201720-B1 | Printing fluid additives promoting overcoat adhesion | HEWLETT PACKARD CO (US) | 2004-09-15 | — | — | EP | claimed |
| US-5134073-A | Culture product of zoogloea ramigera | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1992-07-28 | — | — | US | claimed |
| EP-4736944-A2 | POLYPEPTIDES AND USES THEREOF | MedImmune Limited (GB) | 2026-05-06 | — | — | EP | disclosed |
| EP-4263586-B1 | POLYPEPTIDES AND USES THEREOF | MEDIMMUNE LTD (GB) | 2026-03-11 | — | — | EP | disclosed |
| US-20250289860-A1 | POLYPEPTIDES AND USES THEREOF | MEDIMMUNE LTD (GB) | 2025-09-18 | — | — | US | disclosed |
| US-20240067693-A1 | POLYPEPTIDES AND USES THEREOF | MEDIMMUNE LIMITED (GB) | 2024-02-29 | — | — | US | disclosed |
| US-11872262-B2 | Means and methods for treating bacterial infections | VIB VZW (BE) | 2024-01-16 | — | — | US | disclosed |
| US-11872262-B2 | Means and methods for treating bacterial infections | VIB VZW (BE) | 2024-01-16 | — | — | US | disclosed |
| WO-2022129254-A1 | POLYPEPTIDES AND USES THEREOF | MEDIMMUNE LIMITED (GB) | 2022-06-23 | — | — | WO | disclosed |
| US-20220178931-A1 | Sensor | UNIV BRISTOL (GB) | 2022-06-09 | — | — | US | disclosed |
| US-20210077563-A1 | Means and Methods for Treating Bacterial Infections | VIB VZW (BE) | 2021-03-18 | — | — | US | disclosed |
| US-20190099525-A1 | METHOD FOR PRODUCING ANTITHROMBOTIC COATING MATERIAL | TERUMO KABUSHIKI KAISHA (JP) | 2019-04-04 | — | — | US | disclosed |
| US-10188774-B2 | Method for producing antithrombotic coating material | TERUMO KABUSHIKI KAISHA (JP) | 2019-01-29 | — | — | US | disclosed |
| US-20160263294-A1 | METHOD FOR PRODUCING ANTITHROMBOTIC COATING MATERIAL | TERUMO KABUSHIKI KAISHA (JP) | 2016-09-15 | — | — | US | disclosed |